Searchable abstracts of presentations at key conferences in endocrinology

ea0050p322 | Obesity and Metabolism | SFEBES2017

Cholestatic pregnancy alters the gut incretin response to diet, affecting GLP-1, PYY and FGF19 secretion, with reversal of changes associated with ursodeoxycholic acid treatment

Ovadia Caroline , Chambers Jenny , Martineau Marcus , Murphy Kevin , Walters Julian , Williamson Catherine

Introduction: Intrahepatic cholestasis of pregnancy (ICP) is characterised by maternal pruritus and raised serum bile acids, and is associated with adverse fetal outcomes (e.g. preterm birth, neonatal unit admission and stillbirth). Maternal metabolic impacts include higher rates of gestational diabetes mellitus, hypertriglyceridaemia and hypercholesterolaemia. Glucose and lipid metabolism are influenced by gut incretin release, and bile acids are ...

ea0050p321 | Obesity and Metabolism | SFEBES2017

Rectal and oral administration of L-Phenylalanine supresses food intake and modulates neuronal activation in appetite-regulating brain regions in rodents

Norton Mariana , Cao Ye , Amarsi Risha , Freitas Isabel Fernandes , Alamshah Amin , Murphy Kevin G

High protein diets are highly satiating but hard to maintain. By understanding the mechanisms underlying these effects we may be able to identify new anti-obesity therapies. Protein is broken-down into amino acids in the gut which are detected by a series of nutrient sensors. The calcium sensing receptor (CaSR) is primarily activated by calcium ions, but is positively allosterically modulated by aromatic amino acids, especially L-phenylalanine. Sti...

ea0050p322 | Obesity and Metabolism | SFEBES2017

Cholestatic pregnancy alters the gut incretin response to diet, affecting GLP-1, PYY and FGF19 secretion, with reversal of changes associated with ursodeoxycholic acid treatment

Ovadia Caroline , Chambers Jenny , Martineau Marcus , Murphy Kevin , Walters Julian , Williamson Catherine

Introduction: Intrahepatic cholestasis of pregnancy (ICP) is characterised by maternal pruritus and raised serum bile acids, and is associated with adverse fetal outcomes (e.g. preterm birth, neonatal unit admission and stillbirth). Maternal metabolic impacts include higher rates of gestational diabetes mellitus, hypertriglyceridaemia and hypercholesterolaemia. Glucose and lipid metabolism are influenced by gut incretin release, and bile acids are ...

ea0086p49 | Metabolism, Obesity and Diabetes | SFEBES2022

Investigating NtsR1-expressing neurons extending from the duodenum to pancreas

Meyer Leah , Norton Mariana , Rothery Stephen , Phuah Phyllis , Salem Victoria , Murphy Kevin

Neurotensin is widely expressed in the brain and gastrointestinal tract. Centrally, neurotensin acts as a neuropeptide to suppress appetite, induce hypothermia and modulate analgesia. Peripherally, neurotensin inhibits gastric emptying and is reported to aid lipid absorption. There is also evidence that neurotensin can influence glucose homeostasis, though this role is contentious. We have found that neurotensin acutely improves insulin release and glucose tolerance in mice, a...

ea0086p50 | Metabolism, Obesity and Diabetes | SFEBES2022

Single-nucleus RNA sequencing identifies wide-ranging changes in gene expression in mouse nodose ganglia cell populations in response to fasting

Cheng Sijing , Dowsett Georgina , Lam Brian , Norton Mariana , Roberts Anna , Phuah Phyllis , Yeo Giles , Murphy Kevin

Obesity is a leading global health concern. The gut-brain axis is critical to appetite regulation. The vagus nerve represents the major neural pathway between the gastrointestinal tract and the central nervous system, capable of rapidly communicating information about the nutrient content from different regions of the gastrointestinal tract, directly via nutrient receptors expressed on vagal afferents and indirectly by responding to gut hormones and enteric nervous system sign...

ea0086p64 | Metabolism, Obesity and Diabetes | SFEBES2022

Novel contrast enhanced ultrasound imaging approaches to understand and treat gastrointestinal disease

Dunsterville Cecilia , Vie Clotilde , Broughton-Venner Jacob , Tang Meng-Xing , Murphy Kevin , Brown Alastair

About one in six hospital admissions are for a primary diagnosis of gastrointestinal (GI) disease in the UK, according to the British Society of Gastroenterology, and there is a similar incidence of disease in other developed countries. Inflammatory disease of the gut, in particular, alters the release of cytokines and gut hormones. Medication is used to manage GI diseases and endoscopies help visually monitor its progression. However, this procedure is invasive and causes dis...

ea0086p202 | Metabolism, Obesity and Diabetes | SFEBES2022

Identifying the amino acids which mediates the effect of protein on glucagon release

Chung Pei-En , Norton Mariana , Phuah Phyllis , Reimann Frank , Gribble Fiona , Murphy Kevin

Background: The beneficial effects of high protein diets on glucose homeostasis are thought to be in part mediated by the modulation of gastroenteropancreatic hormones by protein-derived metabolites such as amino acids. However, the precise mechanisms by which amino acids drive these beneficial effects are not well understood. Protein intake stimulates both insulin and glucagon release; glucagon is now recognized to have other metabolic roles besides increasing blood glucose l...

ea0065p177 | Metabolism and Obesity | SFEBES2019

Investigating the role of GPR119 in the vagus nerve

Cheng Sijing , Roberts Anna , Norton Mariana , Owen Bryn , Hanyaloglu Aylin , Murphy Kevin

The prevalence of obesity and its associated metabolic diseases are increasing, but current treatments are ineffective or impractical. Understanding how the gut–brain axis senses nutrients to regulate appetite and glucose homeostasis may identify new drug targets and treatments. The G protein-coupled receptor 119 (GPR119) has several endogenous lipid ligands and has been proposed to act as a nutrient sensor in the gastrointestinal tract. GPR119 is expressed on enteroendoc...

ea0034p199 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

The effect of L-cysteine on appetite in humans

Amin Anjali , Agahi Amy , Martin Niamh , Ghatei Mohamed , Bloom Steve , Murphy Kevin

High protein diets suppress appetite and facilitate weight loss, but are difficult to adhere to. Understanding the mechanisms by which protein suppresses appetite may establish targets for more acceptable interventions to treat or prevent obesity. Of particular interest is the concept of functional foods or novel products, which aim to potentiate satiety.Receptor systems that respond to amino acids have been identified. However, the specific mechanisms r...

ea0028p229 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

A putative role for amino acids in appetite regulation

McGavigan Anne , Greenwood Hannah , Kinsey-Jones James , Ghatei Mohammed , Bloom Stephen , Murphy Kevin

Obesity is a major worldwide health problem with limited treatment options. Recent research has highlighted the importance of gastrointestinal (GI) nutrient sensing in the regulation of food intake and metabolism. Protein as a macronutrient induces the strongest feeling of satiety per calorie. However, different types of protein have varying effects on appetite, suggesting protein induced satiety may be due to the specific amino acids generated by protein digestion. We have id...